About this trial
The goal of this observational study is to observe the postoperative dietary intake in older adult hip fracture patients from their day of surgery (day zero) until day three inclusive. The aims of this study are:
Primary aim:
To observe if the postoperative dietary energy intake (kJ/kcal) of older adult hip fracture patients meets Resting Energy Expenditure (REE) needs.
Secondary aims:
To explore if there is a correlation between postoperative dietary intake and length of hospital stay.
To explore the relationship between comorbidity (where reported) and postoperative dietary intake, according to dietary intake.
To explore (if) in the development of postoperative complications (infection, pressure ulcer and VTE), there is a correlation with postoperative dietary intake.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults >60yrs with a confirmed diagnosis of a hip fracture requiring surgical repair.
Disqualifiers
Pathological hip fractures
Traumatic hip fractures - such as a road traffic collision injury.
Patients that cannot speak English due to the need for informed consent.
Patients undergoing oncologic treatment.
Trial population
Prospective older adult hip fracture patients aged 60 and over at the point of admission.
Trial design
Cohort
Prospective
Treatments tested in this trial
Observational
Other interventionObservational prospective study
Treatment groups
Trial outcomes
Primary outcomes
Postoperative dietary energy intake (kJ/kcal) of older adult hip fracture patients meets Resting Energy Expenditure (REE) needs.
REE in kJ/kcal
Secondary outcomes
The Correlation between comorbidity (where reported) and postoperative dietary intake, according to dietary intake.
Correlation between comorbidity and dietary intake
Correlation between Postoperative complications (infection, pressure ulcer and VTE), and postoperative dietary intake.
Link between complications and dietary intake
Postoperative dietary intake
The length of hospital stay.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.